Clinical success of NEORAL absorption profile

Transplantation Proceedings

Volumn 36, Issue 2 SUPPL., 2004, Pages S461-S464

  Uchida, K ^a   Tominaga, Y ^a   Haba, T ^a   Katayama, A ^a   Matsuoka, S ^a   Goto, N ^a   Ueki, T ^a   Kimata, T ^a   Takeda, A ^a   Morozumi, K ^a   Takagi, H ^b   Nakao, A ^c  

^a NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

^b Toukai Hospital   (Japan)

^c NAGOYA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C2; CYCLOSPORIN A;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; DRUG ABSORPTION; DRUG DOSE REGIMEN; DRUG SCREENING; FEMALE; HUMAN; IMMUNOLOGICAL MONITORING; KIDNEY BIOPSY; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; MALE; MICROEMULSION; PRIORITY JOURNAL; SINGLE DRUG DOSE; TREATMENT OUTCOME;

EID: 12144287438     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2004.01.090     Document Type: Article

References (5)

1. Kovarik J.M., et al. Cyclosporine pharmacokinetics and variability from a microemulsion formulation a multicenter investigation in kidney transplant patients. Transplantation. 58:1994;658.
2. Keown P., et al. Absorption profiling of cyclosporine microemulsion (Neoral) during the first 2 weeks after renal transplantation (Canadian Neoral Renal Transplantation Study Group). Transplantation. 72:2001;1024.
3. 0-4 Monitoring in Maintenance Renal Transplant Patients. Transplant Proc. 33:2001;3128.
4. Levy G., et al. C2 monitoring strategy for optimizing cyclosporine immunosuppression. Bio Drugs. 15:2001;279.
5. Levy G., et al. Patient management by Neoral C2 monitoring an international consensus. Transplantation. 73:(suppl):2001;512.